{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:39:31Z","timestamp":1769740771923,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T00:00:00Z","timestamp":1448582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T00:00:00Z","timestamp":1448582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drug\u2013drug interaction (DDI) is becoming a serious clinical safety issue as the use of multiple medications becomes more common. Searching the MEDLINE database for journal articles related to DDI produces over 330,000 results. It is impossible to read and summarize these references manually. As the volume of biomedical reference in the MEDLINE database continues to expand at a rapid pace, automatic identification of DDIs from literature is becoming increasingly important. In this article, we present a random-sampling-based statistical algorithm to identify possible DDIs and the underlying mechanism from the substances field of MEDLINE records. The substances terms are essentially carriers of compound (including protein) information in a MEDLINE record. Four case studies on warfarin, ibuprofen, furosemide and sertraline implied that our method was able to rank possible DDIs with high accuracy (90.0% for warfarin, 83.3% for ibuprofen, 70.0% for furosemide and 100% for sertraline in the top 10% of a list of compounds ranked by p-value). A social network analysis of substance terms was also performed to construct networks between proteins and drug pairs to elucidate how the two drugs could interact.<\/jats:p>","DOI":"10.1038\/srep17357","type":"journal-article","created":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T10:41:01Z","timestamp":1448620861000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["A novel algorithm for analyzing drug-drug interactions from MEDLINE literature"],"prefix":"10.1038","volume":"5","author":[{"given":"Yin","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxwell","family":"Pietsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetan","family":"Nagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zayd","family":"Fadli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Cheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,27]]},"reference":[{"key":"BFsrep17357_CR1","first-page":"371","volume":"40","author":"DW Linda Brewer","year":"2012","unstructured":"Linda Brewer, D. W. Drug interactions that matter. Clinical pharmacology 40, 371\u2013375 (2012).","journal-title":"Clinical pharmacology"},{"key":"BFsrep17357_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s40267-013-0047-7","volume":"29","author":"AM Writers","year":"2013","unstructured":"Writers, A. M. Drug interactions result from a number of underlying pharmacokinetic and pharmacodynamic mechanisms. Drugs & Therapy Perspectives 29, 217\u2013222 (2013).","journal-title":"Drugs & Therapy Perspectives"},{"key":"BFsrep17357_CR3","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.taap.2009.12.016","volume":"243","author":"L Zhang","year":"2010","unstructured":"Zhang, L., Reynolds, K. S., Zhao, P. & Huang, S. M. Drug interactions evaluation: an integrated part of risk assessment of therapeutics. Toxicology and applied pharmacology 243, 134\u2013145, 10.1016\/j.taap.2009.12.016 (2010).","journal-title":"Toxicology and applied pharmacology"},{"key":"BFsrep17357_CR4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.tips.2013.01.006","volume":"34","author":"B Percha","year":"2013","unstructured":"Percha, B. & Altman, R. B. Informatics confronts drug-drug interactions. Trends in pharmacological sciences 34, 178\u2013184, 10.1016\/j.tips.2013.01.006 (2013).","journal-title":"Trends in pharmacological sciences"},{"key":"BFsrep17357_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2165\/00002018-199309010-00005","volume":"9","author":"CA Jankel","year":"1993","unstructured":"Jankel, C. A. & Fitterman, L. K. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug safety 9, 51\u201359 (1993).","journal-title":"Drug safety"},{"key":"BFsrep17357_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1001\/jama.1995.03530010049034","volume":"274","author":"LL Leape","year":"1995","unstructured":"Leape, L. L. et al. Systems analysis of adverse drug events. ADE Prevention Study Group. Jama 274, 35\u201343 (1995).","journal-title":"Jama"},{"key":"BFsrep17357_CR7","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0277-9536(01)00183-6","volume":"55","author":"OP Corrigan","year":"2002","unstructured":"Corrigan, O. P. A risky business: the detection of adverse drug reactions in clinical trials and post-marketing exercises. Social science & medicine 55, 497\u2013507 (2002).","journal-title":"Social science & medicine"},{"key":"BFsrep17357_CR8","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1177\/0091270007312153","volume":"48","author":"SM Huang","year":"2008","unstructured":"Huang, S. M. et al. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters and the guidance process. Journal of clinical pharmacology 48, 662\u2013670, 10.1177\/0091270007312153 (2008).","journal-title":"Journal of clinical pharmacology"},{"key":"BFsrep17357_CR9","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1124\/dmd.109.028746","volume":"38","author":"SK Quinney","year":"2010","unstructured":"Quinney, S. K. et al. Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin. Drug metabolism and disposition: the biological fate of chemicals 38, 241\u2013248, 10.1124\/dmd.109.028746 (2010).","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"BFsrep17357_CR10","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/clpt.2008.150","volume":"84","author":"H Schelleman","year":"2008","unstructured":"Schelleman, H. et al. Warfarin with fluoroquinolones, sulfonamides, or azole antifungals: interactions and the risk of hospitalization for gastrointestinal bleeding. Clinical pharmacology and therapeutics 84, 581\u2013588, 10.1038\/clpt.2008.150 (2008).","journal-title":"Clinical pharmacology and therapeutics"},{"key":"BFsrep17357_CR11","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/amiajnl-2012-000935","volume":"19","author":"S Vilar","year":"2012","unstructured":"Vilar, S. et al. Drug-drug interaction through molecular structure similarity analysis. Journal of the American Medical Informatics Association: JAMIA 19, 1066\u20131074, 10.1136\/amiajnl-2012-000935 (2012).","journal-title":"Journal of the American Medical Informatics Association: JAMIA"},{"key":"BFsrep17357_CR12","doi-asserted-by":"publisher","first-page":"e58321","DOI":"10.1371\/journal.pone.0058321","volume":"8","author":"S Vilar","year":"2013","unstructured":"Vilar, S., Uriarte, E., Santana, L., Tatonetti, N. P. & Friedman, C. Detection of drug-drug interactions by modeling interaction profile fingerprints. PloS one 8, e58321, 10.1371\/journal.pone.0058321 (2013).","journal-title":"PloS one"},{"key":"BFsrep17357_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature08506","volume":"462","author":"MJ Keiser","year":"2009","unstructured":"Keiser, M. J. et al. Predicting new molecular targets for known drugs. Nature 462, 175\u2013181, 10.1038\/nature08506 (2009).","journal-title":"Nature"},{"key":"BFsrep17357_CR14","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nbt1338","volume":"25","author":"MA Yildirim","year":"2007","unstructured":"Yildirim, M. A., Goh, K. I., Cusick, M. E., Barabasi, A. L. & Vidal, M. Drug-target network. Nature biotechnology 25, 1119\u20131126, 10.1038\/nbt1338 (2007).","journal-title":"Nature biotechnology"},{"key":"BFsrep17357_CR15","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/bioinformatics\/btp465","volume":"25","author":"SI Berger","year":"2009","unstructured":"Berger, S. I. & Iyengar, R. Network analyses in systems pharmacology. Bioinformatics 25, 2466\u20132472, 10.1093\/bioinformatics\/btp465 (2009).","journal-title":"Bioinformatics"},{"key":"BFsrep17357_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1126\/science.1158140","volume":"321","author":"M Campillos","year":"2008","unstructured":"Campillos, M., Kuhn, M., Gavin, A. C., Jensen, L. J. & Bork, P. Drug target identification using side-effect similarity. Science 321, 263\u2013266, 10.1126\/science.1158140 (2008).","journal-title":"Science"},{"key":"BFsrep17357_CR17","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes and disease. Science 313, 1929\u20131935, 10.1126\/science.1132939 (2006).","journal-title":"Science"},{"key":"BFsrep17357_CR18","doi-asserted-by":"publisher","first-page":"i547","DOI":"10.1093\/bioinformatics\/btq382","volume":"26","author":"L Tari","year":"2010","unstructured":"Tari, L., Anwar, S., Liang, S., Cai, J. & Baral, C. Discovering drug-drug interactions: a text-mining and reasoning approach based on properties of drug metabolism. Bioinformatics 26, i547\u2013553, 10.1093\/bioinformatics\/btq382 (2010).","journal-title":"Bioinformatics"},{"key":"BFsrep17357_CR19","unstructured":"Percha, B., Garten, Y. & Altman, R. B. Discovery and explanation of drug-drug interactions via text mining. Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 410\u2013421 (2012)."},{"key":"BFsrep17357_CR20","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/1471-2105-12-S2-S1","volume":"12","author":"I Segura-Bedmar","year":"2011","unstructured":"Segura-Bedmar, I., Martinez, P. & de Pablo-Sanchez, C. A linguistic rule-based approach to extract drug-drug interactions from pharmacological documents. BMC bioinformatics 12 Suppl 2, S1, 10.1186\/1471-2105-12-S2-S1 (2011).","journal-title":"BMC bioinformatics"},{"key":"BFsrep17357_CR21","doi-asserted-by":"crossref","unstructured":"Yan, S., Jiang, X. & Chen, Y. Text Mining Driven Drug-Drug Interaction Detection. Proceedings. IEEE International Conference on Bioinformatics and Biomedicine, 349\u2013355, 10.1109\/BIBM.2013.6732517 (2013).","DOI":"10.1109\/BIBM.2013.6732517"},{"key":"BFsrep17357_CR22","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jbi.2009.03.010","volume":"42","author":"Z Wang","year":"2009","unstructured":"Wang, Z. et al. Literature mining on pharmacokinetics numerical data: a feasibility study. Journal of biomedical informatics 42, 726\u2013735, 10.1016\/j.jbi.2009.03.010 (2009).","journal-title":"Journal of biomedical informatics"},{"key":"BFsrep17357_CR23","doi-asserted-by":"publisher","first-page":"e1002614","DOI":"10.1371\/journal.pcbi.1002614","volume":"8","author":"JD Duke","year":"2012","unstructured":"Duke, J. D. et al. Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS computational biology 8, e1002614, 10.1371\/journal.pcbi.1002614 (2012).","journal-title":"PLoS computational biology"},{"key":"BFsrep17357_CR24","doi-asserted-by":"crossref","unstructured":"Tatonetti, N. P., Ye, P. P., Daneshjou, R. & Altman, R. B. Data-driven prediction of drug effects and interactions. Science translational medicine 4, 125ra131, 10.1126\/scitranslmed.3003377 (2012).","DOI":"10.1126\/scitranslmed.3003377"},{"key":"BFsrep17357_CR25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0006-2952(97)00143-3","volume":"54","author":"MA Hamman","year":"1997","unstructured":"Hamman, M. A., Thompson, G. A. & Hall, S. D. Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Biochemical pharmacology 54, 33\u201341 (1997).","journal-title":"Biochemical pharmacology"},{"key":"BFsrep17357_CR26","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1128\/AAC.01483-05","volume":"50","author":"VV Hynninen","year":"2006","unstructured":"Hynninen, V. V. et al. Effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of s-(+)- and R-(\u2212)-Ibuprofen. Antimicrobial agents and chemotherapy 50, 1967\u20131972, 10.1128\/AAC.01483-05 (2006).","journal-title":"Antimicrobial agents and chemotherapy"},{"key":"BFsrep17357_CR27","doi-asserted-by":"publisher","first-page":"7563","DOI":"10.1073\/pnas.96.13.7563","volume":"96","author":"TD Warner","year":"1999","unstructured":"Warner, T. D. et al. Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proceedings of the National Academy of Sciences of the United States of America 96, 7563\u20137568 (1999).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep17357_CR28","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1592\/phco.25.2.303.56955","volume":"25","author":"DE Havrda","year":"2005","unstructured":"Havrda, D. E., Mai, T. & Chonlahan, J. Enhanced antithrombotic effect of warfarin associated with low-dose alcohol consumption. Pharmacotherapy 25, 303\u2013307, 10.1592\/phco.25.2.303.56955 (2005).","journal-title":"Pharmacotherapy"},{"key":"BFsrep17357_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1177\/0091270004271404","volume":"45","author":"DJ Greenblatt","year":"2005","unstructured":"Greenblatt, D. J. & von Moltke, L. L. Interaction of warfarin with drugs, natural substances and foods. Journal of clinical pharmacology 45, 127\u2013132, 10.1177\/0091270004271404 (2005).","journal-title":"Journal of clinical pharmacology"},{"key":"BFsrep17357_CR30","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/01.GIM.0000153664.65759.CF","volume":"7","author":"S Sanderson","year":"2005","unstructured":"Sanderson, S., Emery, J. & Higgins, J. CYP2C9 gene variants, drug dose and bleeding risk in warfarin-treated patients: a HuGEnet systematic review and meta-analysis. Genetics in medicine: official journal of the American College of Medical Genetics 7, 97\u2013104, 10.109701.GIM.0000153664.65759.CF (2005).","journal-title":"Genetics in medicine: official journal of the American College of Medical Genetics"},{"key":"BFsrep17357_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2006.10.021","volume":"120","author":"T Yin","year":"2007","unstructured":"Yin, T. & Miyata, T. Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1\u2014rationale and perspectives. Thrombosis research 120, 1\u201310, 10.1016\/j.thromres.2006.10.021 (2007).","journal-title":"Thrombosis research"},{"key":"BFsrep17357_CR32","doi-asserted-by":"publisher","first-page":"e44S","DOI":"10.1378\/chest.11-2292","volume":"141","author":"W Ageno","year":"2012","unstructured":"Ageno, W. et al. Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141, e44S\u201388S, 10.1378\/chest.11-2292 (2012).","journal-title":"Chest"},{"key":"BFsrep17357_CR33","first-page":"372","volume":"16","author":"TW Wilson","year":"1993","unstructured":"Wilson, T. W., Badahman, A. H. & Kaushal, R. D. Thromboxane synthase inhibition enhances furosemide-induced renal vasodilation. Clin Invest Med 16, 372\u2013378 (1993).","journal-title":"Clin Invest Med"},{"key":"BFsrep17357_CR34","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S1734-1140(12)70920-9","volume":"64","author":"K Lubelska","year":"2012","unstructured":"Lubelska, K. et al. Interactions between drugs and sulforaphane modulate the drug metabolism enzymatic system. Pharmacol Rep 64, 1243\u20131252 (2012).","journal-title":"Pharmacol Rep"},{"key":"BFsrep17357_CR35","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/dmd.104.002428","volume":"33","author":"RS Obach","year":"2005","unstructured":"Obach, R. S., Cox, L. M. & Tremaine, L. M. Sertraline is metabolized by multiple cytochrome P450 enzymes, monoamine oxidases and glucuronyl transferases in human: an in vitro study. Drug metabolism and disposition: the biological fate of chemicals 33, 262\u2013270, 10.1124\/dmd.104.002428 (2005).","journal-title":"Drug metabolism and disposition: the biological fate of chemicals"},{"key":"BFsrep17357_CR36","first-page":"659","volume":"33","author":"SH Preskorn","year":"1997","unstructured":"Preskorn, S. H., Alderman, J., Greenblatt, D. J. & Horst, W. D. Sertraline does not inhibit cytochrome P450 3A-mediated drug metabolism in vivo. Psychopharmacol Bull 33, 659\u2013665 (1997).","journal-title":"Psychopharmacol Bull"},{"key":"BFsrep17357_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00006565-199910000-00006","volume":"15","author":"BZ Horowitz","year":"1999","unstructured":"Horowitz, B. Z. & Mullins, M. E. Cyproheptadine for serotonin syndrome in an accidental pediatric sertraline ingestion. Pediatr Emerg Care 15, 325\u2013327 (1999).","journal-title":"Pediatr Emerg Care"},{"key":"BFsrep17357_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1034\/j.1600-0447.2000.102004250.x","volume":"102","author":"KS Sayal","year":"2000","unstructured":"Sayal, K. S., Duncan-McConnell, D. A., McConnell, H. W. & Taylor, D. M. Psychotropic interactions with warfarin. Acta psychiatrica Scandinavica 102, 250\u2013255 (2000).","journal-title":"Acta psychiatrica Scandinavica"},{"key":"BFsrep17357_CR39","doi-asserted-by":"publisher","first-page":"139e","DOI":"10.1592\/phco.30.4.422","volume":"30","author":"H Hardy","year":"2010","unstructured":"Hardy, H., Backman, E. S. & Farber, H. W. Successful bosentan and nonnucleoside reverse transcriptase inhibitor-based therapy in a patient with acquired immunodeficiency syndrome and pulmonary arterial hypertension. Pharmacotherapy 30, 139e\u2013144e, 10.1592\/phco.30.4.422 (2010).","journal-title":"Pharmacotherapy"},{"key":"BFsrep17357_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1137\/S003614450342480","volume":"45","author":"MEJ Newman","year":"2003","unstructured":"Newman, M. E. J. The Structure and Function of Complex Networks. SIAM Rev. 45, 167\u2013256 (2003).","journal-title":"SIAM Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep17357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17357","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17357.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:42:19Z","timestamp":1672947739000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep17357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep17357"],"URL":"https:\/\/doi.org\/10.1038\/srep17357","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,27]]},"assertion":[{"value":"22 July 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17357"}}